Ângela Saito

Ângela Saito

Brazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2014 in Langmuir
Verified
Journal Article
Closed access
LCLarissa Brentano Capeletti
Larissa Brentano Capeletti
LOLuciane França de Oliveira
Luciane França de Oliveira
KGKaliandra de Almeida Gonçalves
Kaliandra de Almeida Gonçalves
JOJessica Fernanda Affonso de Oliveira
Jessica Fernanda Affonso de Oliveira
ÂSÂngela Saito
Ângela Saito
MCMateus Borba Cardoso
Mateus Borba Cardoso

30 September 2009 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
SMSandra R. Mirandola
Sandra R. Mirandola
DMDaniela R. Melo
Daniela R. Melo
ÂSÂngela Saito
Ângela Saito
RCRoger Frigério Castilho
Roger Frigério Castilho

2 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JOJessica Fernanda Affonso de Oliveira
Jessica Fernanda Affonso de Oliveira
ÂSÂngela Saito
Ângela Saito
ABAriadne Tuckmantel Bido
Ariadne Tuckmantel Bido
JKJörg Kobarg
Jörg Kobarg
HSHubert Karl Stassen
Hubert Karl Stassen
MCMateus Borba Cardoso
Mateus Borba Cardoso
The rational synthesis of alternative materials is highly demanding due to the outbreak of infectious diseases and resistance to antibiotics. Herein, we report a tailored nanoantibiotic synthesis protocol where the antibiotic binding was optimized on the silver-silica core-shell nanoparticles surface to maximize biological responses. The obtained silver nanoparticles coated with mesoporous silica functionalized with ampicillin presented remarkable antimicrobial effects against susceptible and antibiotic-resistant Escherichia coli. In addition, these structures were not cell-death inducers and different steps of the mitotic cell cycle (prophase, anaphase and metaphase) were clearly identified. The superior biological results were attributed to a proper and tailored synthesis strategy.

23 February 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JXJose Xavier-Neto
Jose Xavier-Neto
MCMurilo Carvalho
Murilo Carvalho
BPBruno dos Santos Pascoalino
Bruno dos Santos Pascoalino
ACAlisson Campos Cardoso
Alisson Campos Cardoso
ÂCÂngela Maria Sousa Costa
Ângela Maria Sousa Costa
KFKleber Franchini
Kleber Franchini
The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5–9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes. Previously thought to produce a harmless bout of fever associated with skin rash and muscle, or joint pain, the Zika virus (ZIKV) is an important cause of morbidity/mortality to human embryos/fetuses. Different from other models, here we report data from wild-type immunocompetent mice, rather than transgenic animals with suppressed immune responses. We found that intravascular ZIKV produced infection of maternal tissues, placentas and conceptuses, but that embryos/fetuses were comparatively much more affected than pregnant females, which seemed to tolerate well the viral challenge with no signs of encephalopathy. Importantly, 10.5 days post-coitum (dpc) embryos exposed to ZIKV at embryonic day 5 (second week in humans) displayed dysraphia, which is a regional failure of neural tube closure, and hydrocephalus, which is a symptom recently shown to precede microcephaly in humans. Characteristic phenotypes in more developed embryos/fetuses included abnormal articular postures analogous to arthrogryposis, which are typical human congenital contractures, gross and generalized malformations and intra uterine growth restriction (IUGR), rather than isolated microcephaly. Some developmental abnormalities and IUGR correlated with placental damage, suggesting that loss of placental function may play an important role in the disease. We believe our model is an asset in the search for useful concepts and prospective therapies for ZIKV because it better reproduces the human condition.

22 July 2010 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
ÂSÂngela Saito
Ângela Saito
RCRoger Frigério Castilho
Roger Frigério Castilho

1 August 2021 in iScience
Verified
Journal Article
Open access
MFMatheus Fonseca
Matheus Fonseca
JOJuliana Ferreira de Oliveira
Juliana Ferreira de Oliveira
BABruno Araujo
Bruno Araujo
CCCamila Canateli
Camila Canateli
PPPaula Favoretti Vital Do Prado
Paula Favoretti Vital Do Prado
KFKleber Gomes Franchini
Kleber Gomes Franchini
Current studies estimate that 1–3% of females with unexplained intellectual disability (ID) present de novo splice site, nonsense, frameshift, or missense mutations in the DDX3X protein (DEAD-Box Helicase 3 X-Linked). However, the cellular and molecular mechanisms by which DDX3X mutations impair brain development are not fully comprehended. Here, we show that the ID-linked missense mutation L556S renders DDX3X prone to aggregation. By using a combination of biophysical assays and imaging approaches, we demonstrate that this mutant assembles solid-like condensates and amyloid-like fibrils. Although we observed greatly reduced expression of the mutant allele in a patient who exhibits skewed X inactivation, this appears to be enough to sequestrate healthy proteins into solid-like ectopic granules, compromising cell function. Therefore, our data suggest ID-linked DDX3X L556S mutation as a disorder arising from protein misfolding and aggregation.